In Brief: Nasal sleep-aid
This article was originally published in The Tan Sheet
Executive Summary
Nasal sleep-aid: Nastech files IND with FDA to begin clinical trials on a nasal delivery formulation of doxylamine succinate as a sleep-aid. The Hauppauge, N.Y. R&D firm said it is currently discussing with FDA whether the nasal spray should be pursued as an OTC or prescription product. Nastech expects to test five different doses of the spray to determine the lowest effective dose...